Stock VO2 VO2 CAP HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Vo2 Cap Holding AB

Equities

VO2

SE0016802797

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-06-11 pm EDT 		5-day change 1st Jan Change
2.91 SEK 0.00% Intraday chart for Vo2 Cap Holding AB -3.32% -0.34%
2023 Ratsave AB acquired additional minority stake in Vo2 Cap Holding AB (OM:VO2) from Oskar Sardi. CI
2023 Vo2 Cap Holding AB (OM:VO2) entered into an agreement to acquire Madington Ab for SEK 65 million. CI

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 - - 155.6 - -
Enterprise Value (EV) 1 - - 267.6 234.6 190.6
P/E ratio - 29.2 x 36.4 x 8.08 x 5.71 x
Yield - - - - -
Capitalization / Revenue - - 0.41 x 0.36 x 0.34 x
EV / Revenue - - 0.7 x 0.54 x 0.42 x
EV / EBITDA - - 9.23 x 5.33 x 3.6 x
EV / FCF - - -33.5 x 7.11 x 4.33 x
FCF Yield - - -2.99% 14.1% 23.1%
Price to Book - - 0.68 x 0.63 x 0.56 x
Nbr of stocks (in thousands) - - 53,481 - -
Reference price 2 5.900 2.920 2.910 2.910 2.910
Announcement Date 2/10/23 2/9/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 466.7 345 381 432 454
EBITDA 1 - 15.5 29 44 53
EBIT 1 - -31.74 8 26 36
Operating Margin - -9.2% 2.1% 6.02% 7.93%
Earnings before Tax (EBT) 1 - 4.26 5 24 35
Net income 1 13.22 5.563 4 19 27
Net margin 2.83% 1.61% 1.05% 4.4% 5.95%
EPS 2 - 0.1000 0.0800 0.3600 0.5100
Free Cash Flow 1 - - -8 33 44
FCF margin - - -2.1% 7.64% 9.69%
FCF Conversion (EBITDA) - - - 75% 83.02%
FCF Conversion (Net income) - - - 173.68% 162.96%
Dividend per Share - - - - -
Announcement Date 2/10/23 2/9/24 - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 - - 112 79 35
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) - - 3.862 x 1.795 x 0.6604 x
Free Cash Flow 1 - - -8 33 44
ROE (net income / shareholders' equity) - - 2% 8% 11%
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 2 - - 4.270 4.620 5.170
Cash Flow per Share - - - - -
Capex 1 - - 1 1 1
Capex / Sales - - 0.26% 0.23% 0.22%
Announcement Date 2/10/23 2/9/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Vo2 Cap Holding AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
VO2 CAP HOLDING AB Stock Vo2 Cap Holding AB
-0.34% 14.81M
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+33.63% 8.68B
SECTRA AB Stock Sectra AB
+38.91% 4.56B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-29.85% 2.72B
VERADIGM INC. Stock Veradigm Inc.
-9.44% 1.61B
OMNICELL, INC. Stock Omnicell, Inc.
-21.87% 1.34B
LUNIT INC. Stock Lunit Inc.
-37.12% 1.08B
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+2.26% 929M
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-42.75% 791M
SURGICAL SCIENCE SWEDEN AB Stock Surgical Science Sweden AB
-23.56% 675M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. VO2 Stock
  4. Financials Vo2 Cap Holding AB